US Edition
What It Took to Make LEN for PrEP Possible + What’s at Risk Now
Summary by AVAC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
What It Took to Make LEN for PrEP Possible + What’s at Risk Now
The US presidential administration released its full US FY26 budget proposal on Friday, and it includes a series of devastating cuts that threaten to roll back HIV prevention efforts in the US and globally by decades. In a cruel irony, this proposal comes just as the field reaches a moment of historic promise in HIV prevention. Lenacapavir (LEN), the twice-yearly injectable form of HIV PrEP, is expected to be approved by the US Food and Drug Ad…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
